Literature DB >> 16471094

Perinatal effects of amphetamine and heroin use during pregnancy on the mother and infant.

Pimolrat Thaithumyanon1, Sompop Limpongsanurak, Pramote Praisuwanna, Santi Punnahitanon.   

Abstract

OBJECTIVES: To determine the perinatal impacts of heroin and amphetamine on both mothers and infants. MATERIAL AND
METHOD: This is a retrospective study on the influence of amphetamine and heroin on pregnant women and their newborn infants at King Chulalongkorn Memorial Hospital in Bangkok, Thailand, between January 1997 and December 2002. The medical and demographic data of both mothers and infants were evaluated. Comparison of the consistent drug effects of these 2 drugs on the mothers and infants were also performed
RESULTS: Two hundred and eleven women were identified There were 178 (84.4%) and 33 (15.6%) women addicted to amphetamine and heroin respectively. Sixty one (28.9%) of them were polydrug users. There were more polydrug users among heroin addicts than amphetamine addicts, (43.7% vs 27.2%, p < 0.05). Poor obstetric history were noted in both groups of women including lack of prenatal care (74.9%), a high incidence of previous abortion (22.3%), positive HIV serology test (11.1%), pre-eclampsia (5.2%), infection (3.3%) and antepartum hemorrhage (1.9%). Drug intoxication was found in 11 amphetamine addicted mothers, whereas 2 heroin addicts developed withdrawal symptoms during intrapartum and postpartum periods. All infants were singleton. There was one stillbirth and 2 neonatal deaths. There was no statistical difference in terms of sex ratio, mean birth weight, gestational age, length, head circumference and Apgar score between the groups of amphetamine and heroin exposed infants. The incidence of prematurity, low birth weight, IUGR and microcephaly were not statistically different between both groups of infants. The overall incidence was 31.7%, 31.7%, 9.5% and 8.6% respectively. Congenital anomalies were found in 5 (2.8%) amphetamine exposed infants. Thirty one out of 33 heroin exposed infants (93.9%) and 4 out of 178 amphetamine exposed infants (2.2%) developed drug withdrawal symptoms with the mean onset of 21.5 +/- 16.5 hours and 10.3 +/- 7.5 hours respectively, p > 0.05. All heroin withdrawal infants were successfully treated with Phenobarbital with the mean duration of treatment of 23.7 +/- 11.5 days. None of the amphetamine withdrawal infants needed specific treatment. They recovered spontaneously within 6.0 +/- 5.3 days. Eighteen infants were left in an orphanage or under the custody of their relatives.
CONCLUSION: Amphetamine or heroin use during pregnancy can cause many serious adverse effects on both mothers and infants. The findings in the present study are consistent with previous reports, although they seemed to be more common and severe. Increasing awareness and improving understanding of drug abuse in the medical, legal and social aspects are needed in order to reduce these impacts.

Entities:  

Mesh:

Year:  2005        PMID: 16471094

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  10 in total

1.  Characteristics of drug use among pregnant women in the United States: Opioid and non-opioid illegal drug use.

Authors:  Verena E Metz; Qiana L Brown; Silvia S Martins; Joseph J Palamar
Journal:  Drug Alcohol Depend       Date:  2017-12-27       Impact factor: 4.492

2.  Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study.

Authors:  Isabelle Lacroix; Alain Berrebi; Daniel Garipuy; Laurent Schmitt; Yamina Hammou; Catherine Chaumerliac; Maryse Lapeyre-Mestre; Jean-Louis Montastruc; Christine Damase-Michel
Journal:  Eur J Clin Pharmacol       Date:  2011-05-03       Impact factor: 2.953

3.  Generational Effects of Opioid Exposure.

Authors:  Katherine E Odegaard; Gurudutt Pendyala; Sowmya V Yelamanchili
Journal:  Encyclopedia (Basel, 2021)       Date:  2021-01-18

Review 4.  Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review.

Authors:  Jennifer N Lind; Julia D Interrante; Elizabeth C Ailes; Suzanne M Gilboa; Sara Khan; Meghan T Frey; April L Dawson; Margaret A Honein; Nicole F Dowling; Hilda Razzaghi; Andreea A Creanga; Cheryl S Broussard
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

5.  Fetal Growth Outcomes in a Cohort of Polydrug- and Opioid-Dependent Patients.

Authors:  Laura Garrison; Lawrence Leeman; Renate D Savich; Hilda Gutierrez; William F Rayburn; Ludmila N Bakhireva
Journal:  J Reprod Med       Date:  2016 Jul-Aug       Impact factor: 0.142

6.  Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the Growth and Development of Their Offspring in Early Childhood.

Authors:  Dana Serino Ma; Bradley S Peterson Md; Tove S Rosen Md
Journal:  J Dual Diagn       Date:  2018-09-05

7.  Amphetamine-Decreased Progesterone and Estradiol Release in Rat Granulosa Cells: The Regulatory Role of cAMP- and Ca2+-Mediated Signaling Pathways.

Authors:  Chung-Yu Chen; Chien-Rung Chen; Chiao-Nan Chen; Paulus S Wang; Toby Mündel; Yi-Hung Liao; Shiow-Chwen Tsai
Journal:  Biomedicines       Date:  2021-04-29

8.  Parenteral Pethidine for labour pain relief and substance use disorder: 20-year follow-up cohort study in offspring.

Authors:  Robert Rodrigues Pereira; Humphrey Kanhai; Frits Rosendaal; Paula van Dommelen; Dick Swaab; Erik Rodrigues Pereira; Ben van de Wetering
Journal:  BMJ Open       Date:  2012-05-30       Impact factor: 2.692

9.  Maternal and Neonatal Complications of Methamphetamine Use during Pregnancy.

Authors:  Suthanud Premchit; Nawabhorn Orungrote; Sinart Prommas; Buppa Smanchat; Kornkarn Bhamarapravatana; Komsun Suwannarurk
Journal:  Obstet Gynecol Int       Date:  2021-04-19

10.  The rate of addiction in parents of toddlers with congenital heart disease.

Authors:  Iraj Sahramian; Noor Mohammad Noori; Abdolvahab Moradi; Forugh Forghani; Elham Sharafi
Journal:  Int J High Risk Behav Addict       Date:  2013-03-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.